Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Frontal fibrosing alopecia in Bogotá mainly affects postmenopausal women, with possible links to hormonal changes and sunscreen use.

Overexpressing the mineralocorticoid receptor in mouse skin causes skin thinning, early skin barrier development, eye issues, and hair loss.

Frontal fibrosing alopecia mostly affects postmenopausal women, with diagnosis often delayed by 3 years.

Using topical prostaglandin F2α for glaucoma may cause loss of eyelash or eyebrow pigment.

Frontal fibrosing alopecia in men is often misdiagnosed and needs better diagnostic criteria and treatment strategies.

RNA aptamers can specifically block FGF5-related cell growth, potentially treating related diseases or hair disorders.

Improved Finasteride delivery for hair loss treatment.

Some fibroblast growth factors may promote hair growth similarly to minoxidil and could potentially treat hair loss.

FGF18 treatment during hair's resting phase can protect against hair loss from radiation.

Combining laser and corticosteroid is not better than corticosteroid alone for treating frontal fibrosing alopecia.

The artificial skin promotes better wound healing and skin regeneration.

Engineered exosomes with EGF and FGF improved hair growth in mice with hair loss.

Minoxidil foam promotes hair growth and reduces hair loss safely in men.

A new sensor can detect minoxidil accurately and effectively.

Fgf20 is crucial for hair follicle formation by influencing cell movement and growth.

Minoxidil nanocrystals improved hair growth in mice more effectively and safely than regular Minoxidil.

Finasteride's molecular properties and active sites were identified using computational methods.

Once-daily 5% minoxidil foam and twice-daily 2% minoxidil solution are similarly effective and safe for female pattern hair loss.

Red light increases hair follicles and ATP in mouse skin.

Limosilactobacillus fermentum MF10 helps hair grow by activating certain cell signals in mice.

Combined microneedling and minoxidil improves hair growth more than minoxidil alone.

Oral dutasteride can potentially treat frontal fibrosing alopecia in postmenopausal women, with some patients showing disease arrest and hair regrowth.

PBM helps improve cell survival in 3D tissue engineering.

Particle properties affect drug retention and release in minoxidil foams, with lipid nanoparticles having higher loading capacity.

Regular use of sunscreen may be linked to frontal fibrosing alopecia.

A 66-year-old woman experienced hair loss due to Frontal Fibrosing Alopecia, a condition with no consistently effective treatment, but it usually stabilizes over time. More research is needed for better understanding and treatment options.

Four new substances—minoxidil, ferrimanitol ovalbumin, clarithromycin, and glucosamine-hydrochloride—can cause occupational asthma.

Prostaglandin F2α may help treat hair loss by promoting hair growth.